SCHEMBL6991145

SCHEMBL6991145

CCN(CC)C(=O)C(=NNc1ccccc1)C(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.50
RAB9A P51151 4/20 0.50
NPC1 O15118 3/20 0.50
MAPK1 P28482 3/20 0.50
KDM4E B2RXH2 2/20 0.50
NPSR1 Q6W5P4 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
GFER P55789 2/20 0.44
ALDH1A1 P00352 6/20 0.43
GAA P10253 4/20 0.42
HTT P42858 1/20 0.42
LMNA P02545 2/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ATM Q13315 1/20 0.40
MEN1 O00255 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991136 1.00 MAPT (0.50) MAPTRAB9ANPC1MAPK1KDM4E
SCHEMBL7485167 0.88 MAPT (0.48) MAPTRAB9ANPC1MAPK1KDM4E
SCHEMBL7485178 0.88 MAPT (0.48) MAPTRAB9ANPC1MAPK1KDM4E
SCHEMBL7482142 0.83 MAPT (0.49) MAPTRAB9ANPC1MAPK1KDM4E
SCHEMBL7482156 0.83 MAPT (0.49) MAPTRAB9ANPC1MAPK1KDM4E
SCHEMBL519257 0.82 MAPT (0.56) MAPTRAB9ANPC1MAPK1KDM4E
SCHEMBL7493335 0.79 MAPT (0.46) MAPTRAB9ANPC1MAPK1KDM4E
SCHEMBL7493347 0.79 MAPT (0.46) MAPTRAB9ANPC1MAPK1KDM4E
SCHEMBL7490754 0.79 MAPT (0.54) MAPTRAB9ANPC1MAPK1KDM4E
SCHEMBL7490755 0.79 MAPT (0.54) MAPTRAB9ANPC1MAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0770081-B1 HETEROCYCLE-CONDENSED MORPHINOID DERIVATIVES GLAXOSMITHKLINE SPA (IT) 2003-04-02 EP disclosed
EP-0712402-B1 HYDROISOQUINOLINE DERIVATIVES SMITHKLINE BEECHAM SPA (IT) 2002-04-10 EP disclosed
US-5981540-A SELECTIVE DELTA OPIOID AGONISTS AND ANTAGONISTS; USEFUL AS ANALGESICS AND IN TREATING GENERAL NEUROLOGIC DISORDERS SMITHKLINE BEECHAM FARMACEUTICI S.P.A. (IT) 1999-11-09 US disclosed
US-5731322-A ADMINISTERING AS ANALGESICS OR IMMUNOMODULATING AND/OR CARDIOVASCULAR AGENTS SMITHKLINE BEECHAM S.P.A. (IT) 1998-03-24 US disclosed
EP-0770081-A1 HETEROCYCLE-CONDENSED MORPHINOID DERIVATIVES SmithKline Beecham Farmaceutici S.p.A. (IT) 1997-05-02 EP disclosed
EP-0712402-A1 HYDROISOQUINOLINE DERIVATIVES Smithkline Beecham S.p.A. (IT) 1996-05-22 EP disclosed
WO-1996002545-A1 HETEROCYCLE-CONDENSED MORPHINOID DERIVATIVES SMITHKLINE BEECHAM S.P.A. (IT) 1996-02-01 WO disclosed
WO-1995004734-A1 HYDROISOQUINOLINE DERIVATIVES SMITHKLINE BEECHAM FARMACEUTICI S.P.A. (IT) 1995-02-16 WO disclosed